Literature DB >> 34450675

Early Vital Sign Differences in Very Low Birth Weight Infants with Severe Intraventricular Hemorrhage.

Santina A Zanelli1, Maryam Abubakar1, Robert Andris1, Kavita Patwardhan2, Karen D Fairchild1, Zachary A Vesoulis2.   

Abstract

OBJECTIVE: Severe intraventricular hemorrhage (sIVH, grades 3 and 4) is a serious complication for very low birth weight (VLBW) infants and is often clinically silent requiring screening cranial ultrasound (cUS) for detection. Abnormal vital sign (VS) patterns might serve as biomarkers to identify risk or occurrence of sIVH. STUDY
DESIGN: This retrospective study was conducted in VLBW infants admitted to two level-IV neonatal intensive care units (NICUs) between January 2009 and December 2018. Inclusion criteria were: birth weight <1.5 kg and gestational age (GA) <32 weeks, at least 12 hours of systemic oxygen saturation from pulse oximetry (SpO2) data over the first 24 hours and cUS imaging. Infants were categorized as early sIVH (sIVH identified in the first 48 hours), late sIVH (sIVH identified after 48 hours and normal imaging in the first 48 hours), and no IVH. Infants with grades 1 and 2 or unknown timing IVH were excluded. Mean heart rate (HR), SpO2, mean arterial blood pressure (MABP), number of episodes of bradycardia (HR < 100 bpm), and desaturation (SpO2 < 80%) were compared.
RESULTS: A total of 639 infants (mean: 27 weeks' gestation) were included (567 no IVH, 34 early sIVH, and 37 late sIVH). In the first 48 hours, those with sIVH had significantly higher HR compared with those with no IVH. Infants with sIVH also had lower mean SpO2 and MABP and more desaturations <80%. No significant differences in VS patterns were identified in early versus late sIVH. Logistic regression identified higher HR and greater number of desaturations <80% as independently associated with sIVH.
CONCLUSION: VLBW infants who develop sIVH demonstrate VS differences with significantly lower SpO2 and higher mean HR over the first 48 hours after birth compared with VLBW infants with no IVH. Abnormalities in early VS patterns may be a useful biomarker for sIVH. Whether VS abnormalities predict or simply reflect sIVH remains to be determined. KEY POINTS: · A higher HR in the first 48 hours is seen in infants with severe IVH.. · Infants with sIVH have lower blood pressure in the first 48 hours.. · Infants with sIVH have more oxygen desaturations in the first 48 hours.. Thieme. All rights reserved.

Entities:  

Year:  2021        PMID: 34450675      PMCID: PMC9188354          DOI: 10.1055/s-0041-1733955

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   3.079


  32 in total

1.  The Diastolic Closing Margin Is Associated with Intraventricular Hemorrhage in Premature Infants.

Authors:  Christopher J Rhee; Kathleen K Kibler; R Blaine Easley; Dean B Andropoulos; Marek Czosnyka; Peter Smielewski; Georgios V Varsos; Ken M Brady; Craig G Rusin; Charles D Fraser; C Heath Gauss; D Keith Williams; Jeffrey R Kaiser
Journal:  Acta Neurochir Suppl       Date:  2016

Review 2.  Intracranial Hemorrhage in the Neonate.

Authors:  Nidhi Agrawal Shah; Courtney J Wusthoff
Journal:  Neonatal Netw       Date:  2016

3.  Implementation of potentially better practices for the prevention of brain hemorrhage and ischemic brain injury in very low birth weight infants.

Authors:  Debra McLendon; Jennifer Check; Patricia Carteaux; Laura Michael; Jim Moehring; Joel W Secrest; Sue E Clark; Howard Cohen; Sharon A Klein; Diane Boyle; Jeffrey A George; Susan Okuno-Jones; Debora S Buchanan; Pam McKinley; Jonathan M Whitfield
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

4.  Correction: Recovery from bradycardia and desaturation events at 32 weeks corrected age and NICU length of stay: an indicator of physiologic resilience?

Authors:  V Peter Nagraj; Robert A Sinkin; Douglas E Lake; J Randall Moorman; Karen D Fairchild
Journal:  Pediatr Res       Date:  2020-03-05       Impact factor: 3.756

Review 5.  Preterm brain injury: Germinal matrix-intraventricular hemorrhage and post-hemorrhagic ventricular dilatation.

Authors:  Lara M Leijser; Linda S de Vries
Journal:  Handb Clin Neurol       Date:  2019

6.  Risk of Severe Intraventricular Hemorrhage in the First Week of Life in Preterm Infants Transported Before 72 Hours of Age.

Authors:  Lara Shipley; Timea Gyorkos; Jon Dorling; Laila J Tata; Lisa Szatkowski; Don Sharkey
Journal:  Pediatr Crit Care Med       Date:  2019-07       Impact factor: 3.624

7.  Incidence, severity, and timing of subependymal and intraventricular hemorrhages in preterm infants born in a perinatal unit as detected by serial real-time ultrasound.

Authors:  T Dolfin; M B Skidmore; K W Fong; E M Hoskins; A T Shennan
Journal:  Pediatrics       Date:  1983-04       Impact factor: 7.124

8.  Application of a Bundle in the Prevention of Peri-Intraventricular Hemorrhage in Preterm Newborns.

Authors:  Daniela Monteiro Ferreira; Ana Lívia Araújo Girão; Ana Valeska Siebra E Silva; Edna Maria Camelo Chaves; Paulo César de Almeida; Vanessa Sousa Freire; Rhanna Emanuela Fontenele Lima de Carvalho
Journal:  J Perinat Neonatal Nurs       Date:  2020 Apr/Jun       Impact factor: 1.638

9.  Blood sampling via umbilical vein catheters decreases cerebral oxygenation and blood volume in preterm infants.

Authors:  Britta M Hüning; Sandra Horsch; Claudia Roll
Journal:  Acta Paediatr       Date:  2007-11       Impact factor: 2.299

10.  The hidden consequence of intraventricular hemorrhage: persistent cerebral desaturation after IVH in preterm infants.

Authors:  Zachary A Vesoulis; Halana V Whitehead; Steve M Liao; Amit M Mathur
Journal:  Pediatr Res       Date:  2020-10-10       Impact factor: 3.756

View more
  1 in total

1.  Clinical Application of Microsurgery Using the Cerebellar Medulla Fissure Approach in Severe Ventricular Hemorrhage with Casting of the Fourth Ventricle and Its Influence on Neurological Recovery.

Authors:  Feng Gao; Huixiao Wang; Zhengzheng Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-25       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.